Orchestra BioMed Holdings Inc.OBIO
▲ ポジティブ技術関連度
BACKBEAT trial on track, FDA Breakthrough Device Designation, and cash runway into Q4 2027.
銘柄への影響 3
Health Care
Orchestra BioMed Holdings Inc.Robotics & Physical AI
Medtronic PLCMDT
▲ ポジティブ技術関連度
Collaboration with Medtronic on BACKBEAT trial and strategic capital investment.
Biotech & Genomic Medicine
Ligand Pharmaceuticals IncorporatedLGND
▲ ポジティブ資本関連度
Ligand provided strategic capital to Orchestra BioMed, indicating financial support.